Impact of early tumor shrinkage on clinical outcome in KRAS wild-type colorectal liver-limited metastases treated with cetuximab plus chemotherapy: Lessons from a randomized controlled trial.
Le-chi Ye
No relevant relationships to disclose
Yunshi Zhong
No relevant relationships to disclose
Tianshu Liu
No relevant relationships to disclose
Ye Wei
No relevant relationships to disclose
Li Ren
No relevant relationships to disclose
Dexiang Zhu
No relevant relationships to disclose
Xinyu Qin
No relevant relationships to disclose
Jia Fan
No relevant relationships to disclose
Jingwen Chen
No relevant relationships to disclose
Wenju Chang
No relevant relationships to disclose
Qi Lin
No relevant relationships to disclose
Jianmin Xu
No relevant relationships to disclose